CTLM ITALIA

CTLM Italia is a medical technology company specializing in advanced breast imaging solutions through the use of Computed Tomography Laser Mammography (CTLM). The company's core technology is a non-invasive, radiation-free diagnostic tool that utilizes laser technology to detect angiogenesis, a hallmark of malignant tumor growth, by measuring hemoglobin concentrations. Designed as an adjunct to traditional X-ray mammography, the CTLM system is particularly effective for women with dense breast tissue where conventional screening may be limited. CTLM Italia provides distribution, clinical training, and technical support for these systems within the Italian healthcare market. The company aims to improve early cancer detection and patient comfort by offering a painless alternative to breast compression and ionizing radiation.